Celery Seed Extract
Phthalide-rich seed extract studied mainly for blood pressure.
What is Celery Seed Extract?
Celery Seed Extract (Apium graveolens) is a heart and metabolic supplement used for lower blood pressure. NutriDex grades the human evidence as Moderate. Celery seed extract is concentrated from Apium graveolens seeds and standardized to phthalides, chiefly 3-n-butylphthalide (3nB), a calcium-channel-modulating vasodilator. A 2025 meta-analysis of 9 RCTs (511 adults) found celery significantly lowered systolic blood pressure (SMD -1.0), diastolic pressure (SMD -0.93), fasting glucose (SMD -0.80) and triglycerides (SMD -1.18), with no clear effect on total, LDL or HDL cholesterol. A triple-blind crossover RCT (~1.34 g/day for 4 weeks) cut systolic pressure ~11 mmHg and diastolic ~8 mmHg in treated hypertensives. However, heterogeneity was very high (I² 77-96%), most trials were small, short, geographically narrow and at moderate-to-high risk of bias, and a 12-week pilot in type-2 diabetes showed no significant between-group cardiometabolic gains. Effects look real but modest and not yet robustly proven; it is an adjunct, not a substitute for prescribed therapy.
Purported Benefits
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Blood pressureMeta-analysis and a crossover RCT (~11/8 mmHg drop) show real BP lowering, but heterogeneity is very high (I2 77-96%). | Moderate | ↑ benefit · moderate | 3 |
| Fasting blood glucoseMeta-analysis and small trials show glucose reduction, but a 12-week T2DM RCT found no between-group benefit. | Mixed | ↔ mixed · small | 3 |
| Triglycerides2025 meta-analysis showed TG reduction (SMD -1.18) but with high heterogeneity and small, short trials. | Preliminary | ↑ benefit · moderate | 1 |
| Bleeding risk with anticoagulants (harm)Review flags additive antiplatelet/anticoagulant interaction; caution with blood thinners. | Preliminary | ⚠ risk | 1 |